The ALG6 Gene Glycosylation Disorder Type 1C NGS Genetic DNA Test is a cutting-edge diagnostic tool that utilizes Next Generation Sequencing (NGS) technology to identify mutations in the ALG6 gene. This test is crucial for understanding glycosylation disorders, which can lead to significant neurological complications. Early detection through this genetic test allows for timely intervention and management of associated symptoms.
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Turnaround Time: 3 to 4 Weeks
Pre-test Instructions: A clinical history of the patient going for the ALG6 Gene Glycosylation Disorder Type 1C NGS Genetic DNA Test is required. A genetic counseling session to draw a pedigree chart of family members affected with ALG6 Gene Glycosylation Disorder Type 1C is also recommended.